These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20651599)

  • 21. Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study.
    Sofi F; Giangrandi I; Cesari F; Corsani I; Abbate R; Gensini GF; Casini A
    Int J Food Sci Nutr; 2010 Dec; 61(8):792-802. PubMed ID: 20465434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
    Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Correlation between hepatocyte cytochrome P450IIE1 expression and oxidation, antioxidation in rat nonalcoholic steatosis model].
    Dai N; Zeng M; Li J
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):104-6. PubMed ID: 10488421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exendin-4 and exercise promotes beta-cell function and mass through IRS2 induction in islets of diabetic rats.
    Park S; Hong SM; Sung SR
    Life Sci; 2008 Feb; 82(9-10):503-11. PubMed ID: 18237751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity.
    Ki SH; Choi JH; Kim CW; Kim SG
    Chem Biol Interact; 2007 Aug; 169(2):80-90. PubMed ID: 17606256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease.
    Wang HN; Wang YR; Liu GQ; Liu Z; Wu PX; Wei XL; Hong TP
    World J Gastroenterol; 2008 Dec; 14(47):7240-6. PubMed ID: 19084941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.
    Pan MH; Lai CS; Tsai ML; Ho CT
    Mol Nutr Food Res; 2014 Jan; 58(1):147-71. PubMed ID: 24302567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sophocarpine alleviates non-alcoholic steatohepatitis in rats.
    Song CY; Zeng X; Chen SW; Hu PF; Zheng ZW; Ning BF; Shi J; Xie WF; Chen YX
    J Gastroenterol Hepatol; 2011 Apr; 26(4):765-74. PubMed ID: 21054517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas.
    Nachnani JS; Bulchandani DG; Nookala A; Herndon B; Molteni A; Pandya P; Taylor R; Quinn T; Weide L; Alba LM
    Diabetologia; 2010 Jan; 53(1):153-9. PubMed ID: 19756486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucagon like-peptide 1 receptor and the liver.
    Pedersen J; Holst JJ
    Liver Int; 2011 Oct; 31(9):1243-5. PubMed ID: 22093450
    [No Abstract]   [Full Text] [Related]  

  • 31. [Omega-3 fatty acids as an option in the treatment of NAFLD].
    Singer P
    MMW Fortschr Med; 2011 Oct; 153 Suppl 3():90-4. PubMed ID: 22184802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor.
    Alwayn IP; Andersson C; Zauscher B; Gura K; Nosé V; Puder M
    Transplantation; 2005 Mar; 79(5):606-8. PubMed ID: 15753852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of omega-3 fatty acids on arrhythmogenic mechanisms in animal and isolated organ/cell culture studies.
    Jordan H; Matthan N; Chung M; Balk E; Chew P; Kupelnick B; DeVine D; Lawrence A; Lichtenstein A; Lau J
    Evid Rep Technol Assess (Summ); 2004 Mar; (92):1-8. PubMed ID: 15133886
    [No Abstract]   [Full Text] [Related]  

  • 34. Ultrastructural and biochemical evidence of cardiac lipofuscinosis after short-term intake of fish oil in rats.
    Yanagisawa A; Sakata K; Satoh K; Mineo S; Ishikawa K
    Ann N Y Acad Sci; 1993 Mar; 676():364-7. PubMed ID: 8489154
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of nitric oxide in the treatment of non-alcoholic fatty liver by omega-3 fatty acids.
    Beyazit Y; Purnak T; Kekilli M
    Aliment Pharmacol Ther; 2010 Jul; 32(2):303-4. PubMed ID: 20636624
    [No Abstract]   [Full Text] [Related]  

  • 36. The optimal dose of omega-3 supplementation for non-alcoholic fatty liver disease.
    Li Y; Chen D
    J Hepatol; 2012 Aug; 57(2):468-9; author reply 469-70. PubMed ID: 22433603
    [No Abstract]   [Full Text] [Related]  

  • 37. [Study on the effect of amino acids on dietary fatty liver. 3. Significance of non-essential amino acids].
    Yoshida R
    Nihon Shonika Gakkai Zasshi; 1968 Apr; 72(4):468-72. PubMed ID: 5692408
    [No Abstract]   [Full Text] [Related]  

  • 38. Omega-3 fatty acids: a promising alternative treatment approach for patients with nonalcoholic fatty liver disease.
    Beyazit Y; Purnak T; Kekilli M
    Dig Dis Sci; 2010 Aug; 55(8):2422-3; author reply 2423. PubMed ID: 20521114
    [No Abstract]   [Full Text] [Related]  

  • 39. Reply - Letter to the Editor: "Effect of a collagen-enriched beverage with or without omega-3 fatty acids on wound healing, metabolic biomarkers, and adipokines in patients with major burns".
    Alipoor E; Jazayeri S; Dahmardehei M; Salehi S; Yaseri M; Emami MR; Rezayat SM; Hosseinzadeh-Attar MJ
    Clin Nutr; 2023 Jul; 42(7):1104-1105. PubMed ID: 37268539
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hepatic steatosis and antibiotics].
    DEMEULENAERE L
    Acta Gastroenterol Belg; 1953 Dec; 16(12:1):791-5. PubMed ID: 13137878
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.